Reports Q3 revenue $7.799M, consensus $8.28M. “Stereotaxis continues to deliver commercial results and advance a robust innovation strategy, while maintaining financial discipline,” said David Fischel, Chairman and CEO. “Revenue growth in the quarter was driven by continued demand for Genesis with revenue recognition of two robotic systems. System revenue growth counteracted the loss of royalties and residual pressure on procedures. A robust system pipeline along with existing system backlog of $13 million supports continued growth in the coming quarters.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on STXS:
- Stereotaxis Reports 2023 Third Quarter Financial Results
- STXS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Abbott and Stereotaxis Technologies Used in First Integrated Procedures in the United States
- Abbott, Stereotaxis report patients treated with integrated tech in the U.S.
- Stereotaxis to Report Third Quarter 2023 Financial Results on November 9, 2023
Questions or Comments about the article? Write to editor@tipranks.com